Castle Biosciences, Inc. (CSTL)
Last updated: 2026-10-21 15:33:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Castle Biosciences, Inc. (CSTL) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $34.43, with a market capitalization of $982.62M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $17.72 to $44.28. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$982.62M | |
$33.15 | |
$107.69 | |
$2.26 | |
$33.15 | |
82.15K | |
405.21K | |
-- | |
$44.28 | |
$17.72 | |
-- | |
-- |
Castle Biosciences, Inc. (CSTL) Stock Price Today
Castle Biosciences, Inc. (CSTL) is currently trading at $34.43 as of 2026-10-21 15:31:00, up 3.86% ($1.28) from the previous close of $33.15
During today's regular trading session, CSTL has traded between $2.26 and $107.69, with a trading volume of 82.15K shares. The current price is near the lower end of today's range.
Castle Biosciences, Inc. (CSTL) 7-Day Stock Price Change
Over the past seven days, Castle Biosciences, Inc. (CSTL) moved from $32.76 to $34.43, representing a gain of 5.10% ($1.67).
The stock traded between $31.67 and $34.67 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 301.08 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
CSTL 52-Week Price Position
Position in Range: 62.9%
CSTL is currently trading at $34.43, placing it 62.9% of the way from its 52-week low of $17.72 to its 52-week high of $44.28. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Castle Biosciences, Inc. (CSTL)?
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.
Castle Biosciences, Inc. Information
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 1002 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Castle Biosciences, Inc. (CSTL) Stock on MEXC
Eligible investors can buy real shares of Castle Biosciences, Inc. (CSTL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Castle Biosciences, Inc. (CSTL) stock price today?
2.Is CSTL stock going up or down today?
3.What is CSTL pre-market price?
4.What is CSTL after-hours price?
5.Is CSTL stock trading now?
6.Where does CSTL sit relative to its 52-week high and low?
7.What sector is Castle Biosciences, Inc. in?
8.What is Castle Biosciences, Inc.'s market capitalization and where is it listed?
9.How is CSTL valued in terms of P/E ratio and EPS?
10.Does Castle Biosciences, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
CSTL Stock Calculator
Estimate the value between CSTL shares and USD.
CSTL Shares to USD
1.00 CSTL shares = 34.43 USD
Calculations are estimates based on the latest available price and are for reference only.



